Welcome to the Serohub, a project of the LEOSS.SERO-Survey and Covim

The platform for seroprevalence
studies on SARS-COV-2

The LEOSS.survey-platform is a crucial and independent infrastructure to accelerate research about teh seroprevalence of SARS-COV-2. Researches, government and industry partners are invited to contribute their knowledge and tools to improve evidence-based decision-making on COVID 19. LEOSS stands for Lean European Open Survey on SARS-COV-2, see more details on

Locations of participating
SARS-COV-2 seroprevalence studies


The LEOSS.survey-platform focuses on four primary aims about sereoprevalence of SARS-COV-2:
a community platform for researcher, a platform for critical appraisal of diagsnostic trials, a platform of study related documents and a cloud based meta analysis platform.



The LEOSS.survey-platform is an open initiative to provide a centralized hub of resources.
Researches can submit SARS-COV-2 seroprevalence studies, publications
and even data included here.

Sponsored by


leoss.sero-survey blog

Stay up to date with the latest opportunities to collaborate on SARS-COV-2 seroprevalence studies.

seroprevalence Studies

Find out about participating SARS-COV-2 seroprevalence studies.


Preprints and pre-reviewed scientific papers about SARS-COV-2 seroprevalence studies.

Participating Studies and Partners

Overview of SARS-COV-2 studies seroprevalence in context of the worldwide  COVID-19 pandemie. You can register a study here: Contribute
@serohub on Twitter
hzi-braunschweig/serohub on GitHub